AGG Food & Drug team leader Alan Minsk is moderating and speaking on the topic “ESG Considerations in Advertising: Promoting Transparency, Patient-Engagement, and Health Equity” at the Food and Drug Law Institute (“FDLI”) Advertising & Promotion for Medical Products Conference on October 13, 2022, from 3-4 p.m. EDT at the Renaissance Washington, D.C. Downtown Hotel.
Environmental, social, and governance (“ESG”) responsibilities have risen in importance among shareholders, consumers, and policy makers seeking to manage investment risk and support ethical purchases. Increasingly, medical products entities are launching ESG initiatives to create equitable, patient-centric business models. Alan and his fellow panelists will discuss ESG considerations for industry and how promoting ESG culture can increase health equity in the medical products field and globally.
The conference will be held from October 13-14, 2022, and will also explore updated government agency initiatives, goals, and priorities; product promotion, marketing, and scientific exchange in a hybrid environment; social media best practices; and trends in enforcement and regulation.
To learn more and register, please click here.